Eurofins Advinus LIMITED
- UEI
- PWA8DJQ6N393
- CAGE
- 3224Y
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- advinus.com
- Founded
- 2005
- Employees
- 251-1K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Custom synthesis of 6 molecules | National Center for Advancing Translational Sciences (NIH) | $11,320 | |
| Eurofins advinus limited genetic toxicology study | National Institute on Drug Abuse (NIH) | $45,750 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Westwind Computer Products, Inc. | 75N92024F00001 | $92,604 |
Similar vendors
About the company
Eurofins Advinus LIMITED is an international, for-profit organization registered in SAM.gov since August 2019, operating as a division of Eurofins. The company appears to be a global scientific services provider with specialization in advanced research and laboratory testing, particularly in pharmaceutical and biomedical domains. While detailed information about the company's full operational scope is not provided in the available data, the federal contract awards suggest the organization offers sophisticated scientific research and synthesis services to U.S. government agencies.
The federal contract awards for Eurofins Advinus LIMITED demonstrate specialized scientific research capabilities across multiple federal agencies. The company has secured two prime federal contract awards: a $11,320 contract with the National Center for Advancing Translational Sciences for custom synthesis of 6 molecules, completed in September 2021, and a $45,750 genetic toxicology study contract with the National Institute on Aging, completed in October 2020. Both contracts were standard purchase orders with no specific set-aside designations. Additionally, the vendor has a pending sub-contract award dated September 29, 2024, with Research Triangle Institute, indicating ongoing collaborative research relationships. The contracts suggest Eurofins Advinus LIMITED provides high-precision scientific services involving molecular synthesis, genetic toxicology studies, and potentially other advanced research methodologies for federal research institutions.
Quick answers
Is Eurofins Advinus LIMITED registered in SAM.gov?
Eurofins Advinus LIMITED's SAM.gov registration expired on February 13, 2023.
What is Eurofins Advinus LIMITED's most recent federal award?
Eurofins Advinus LIMITED's most recent federal contract award is Custom synthesis of 6 molecules (75N95C21P00133), from National Center for Advancing Translational Sciences (NIH), on September 13, 2021.
On GovTribe
See Eurofins Advinus LIMITED's full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors